CZ20021551A3 - Onkolytické kombinace pro léčení rakoviny - Google Patents
Onkolytické kombinace pro léčení rakoviny Download PDFInfo
- Publication number
- CZ20021551A3 CZ20021551A3 CZ20021551A CZ20021551A CZ20021551A3 CZ 20021551 A3 CZ20021551 A3 CZ 20021551A3 CZ 20021551 A CZ20021551 A CZ 20021551A CZ 20021551 A CZ20021551 A CZ 20021551A CZ 20021551 A3 CZ20021551 A3 CZ 20021551A3
- Authority
- CZ
- Czechia
- Prior art keywords
- pgi
- ethyl
- phenoxy
- propoxy
- mmol
- Prior art date
Links
- 0 CCCc(c(Oc(cccc1)c1C(O)=O)ccc1)c1OCCCOc1c(CC)cc(C2=CN=N[N+]2)*(O)c1 Chemical compound CCCc(c(Oc(cccc1)c1C(O)=O)ccc1)c1OCCCOc1c(CC)cc(C2=CN=N[N+]2)*(O)c1 0.000 description 4
- YMRVRPHKINHKQD-UHFFFAOYSA-O CCCC(C(Oc(cccc1)c1OC(C1)C1O)=CCC1C)=C1OCCCOc1c(CC)cc(C(C=N)=C[NH2+]C)c(O)c1 Chemical compound CCCC(C(Oc(cccc1)c1OC(C1)C1O)=CCC1C)=C1OCCCOc1c(CC)cc(C(C=N)=C[NH2+]C)c(O)c1 YMRVRPHKINHKQD-UHFFFAOYSA-O 0.000 description 1
- LKZYTAGHWNMYPS-UHFFFAOYSA-N CCCc(c(COc1ccccc1C(O)=O)ccc1)c1OCCCOc1c(CC)cc(C2C=CSC2C)c(O)c1 Chemical compound CCCc(c(COc1ccccc1C(O)=O)ccc1)c1OCCCOc1c(CC)cc(C2C=CSC2C)c(O)c1 LKZYTAGHWNMYPS-UHFFFAOYSA-N 0.000 description 1
- UEFCLIWWMUBFON-UHFFFAOYSA-N CCCc(c(OC(CCC=C1)=C1C(O)=O)ccc1)c1OCCCOc1c(CC)cc(-c2ccc[o]2)c(O)c1 Chemical compound CCCc(c(OC(CCC=C1)=C1C(O)=O)ccc1)c1OCCCOc1c(CC)cc(-c2ccc[o]2)c(O)c1 UEFCLIWWMUBFON-UHFFFAOYSA-N 0.000 description 1
- HNOYCIHGBFSBDA-UHFFFAOYSA-N CCCc(c(Oc(cccc1)c1C(O)=O)ccc1)c1OCCCOc1c(CC)cc(-c2ccc[s]2)c(O)c1 Chemical compound CCCc(c(Oc(cccc1)c1C(O)=O)ccc1)c1OCCCOc1c(CC)cc(-c2ccc[s]2)c(O)c1 HNOYCIHGBFSBDA-UHFFFAOYSA-N 0.000 description 1
- MGMZNTJPDAKQQM-UHFFFAOYSA-N CCCc(c(Oc(cccc1)c1C(O)=O)ccc1)c1OCCCOc1c(CC)cc(-c2ccn[nH]2)c(O)c1 Chemical compound CCCc(c(Oc(cccc1)c1C(O)=O)ccc1)c1OCCCOc1c(CC)cc(-c2ccn[nH]2)c(O)c1 MGMZNTJPDAKQQM-UHFFFAOYSA-N 0.000 description 1
- SJZXYHPJJMWSTC-UHFFFAOYSA-N CCCc(c(Oc(cccc1)c1C(O)=O)ccc1)c1OCCCOc1c(CC)cc(-c2ccn[o]2)c(O)c1 Chemical compound CCCc(c(Oc(cccc1)c1C(O)=O)ccc1)c1OCCCOc1c(CC)cc(-c2ccn[o]2)c(O)c1 SJZXYHPJJMWSTC-UHFFFAOYSA-N 0.000 description 1
- ZVBJGRGJWUOQDP-UHFFFAOYSA-O CCCc(c(Oc(cccc1)c1C(O)=O)ccc1)c1OCCCOc1c(CC)cc(C2=CN=N[NH2+]2)c(O)c1 Chemical compound CCCc(c(Oc(cccc1)c1C(O)=O)ccc1)c1OCCCOc1c(CC)cc(C2=CN=N[NH2+]2)c(O)c1 ZVBJGRGJWUOQDP-UHFFFAOYSA-O 0.000 description 1
- GEWMTUVWZSKESO-UHFFFAOYSA-N CCCc(c(Oc(cccc1)c1C(OC)=O)ccc1)c1OCCCOc(cc1O)c(CC)cc1-[n]1cccc1 Chemical compound CCCc(c(Oc(cccc1)c1C(OC)=O)ccc1)c1OCCCOc(cc1O)c(CC)cc1-[n]1cccc1 GEWMTUVWZSKESO-UHFFFAOYSA-N 0.000 description 1
- VMHGDAOKCQTBSQ-UHFFFAOYSA-N CCCc(c(Oc1ccccc1C(O)=O)ccc1)c1OCCCOc1c(CC)cc(-c2c[s]cn2)c(O)c1 Chemical compound CCCc(c(Oc1ccccc1C(O)=O)ccc1)c1OCCCOc1c(CC)cc(-c2c[s]cn2)c(O)c1 VMHGDAOKCQTBSQ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16478699P | 1999-11-11 | 1999-11-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CZ20021551A3 true CZ20021551A3 (cs) | 2003-02-12 |
Family
ID=22596085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CZ20021551A CZ20021551A3 (cs) | 1999-11-11 | 2000-11-09 | Onkolytické kombinace pro léčení rakoviny |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1231938A2 (es) |
| JP (1) | JP2003513916A (es) |
| KR (1) | KR20020069512A (es) |
| CN (1) | CN1390139A (es) |
| AR (1) | AR032432A1 (es) |
| AU (1) | AU778829B2 (es) |
| BR (1) | BR0015490A (es) |
| CA (1) | CA2391416A1 (es) |
| CZ (1) | CZ20021551A3 (es) |
| EA (1) | EA200200545A1 (es) |
| HK (1) | HK1050132A1 (es) |
| HU (1) | HUP0204449A3 (es) |
| IL (1) | IL148579A0 (es) |
| MX (1) | MXPA02004733A (es) |
| NO (1) | NO20022245L (es) |
| NZ (1) | NZ517667A (es) |
| PE (1) | PE20010701A1 (es) |
| PL (1) | PL355172A1 (es) |
| SK (1) | SK6492002A3 (es) |
| TR (1) | TR200201245T2 (es) |
| WO (1) | WO2001034137A2 (es) |
| ZA (1) | ZA200202822B (es) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001034198A2 (en) * | 1999-11-11 | 2001-05-17 | Eli Lilly And Company | Oncolytic combinations for the treatment of cancer |
| WO2001034197A2 (en) * | 1999-11-11 | 2001-05-17 | Eli Lilly And Company | Oncolytic combinations for the treatment of cancer |
| US6797723B1 (en) | 1999-11-11 | 2004-09-28 | Eli Lilly And Company | Heterocycle substituted diphenyl leukotriene antagonists |
| JP2001247459A (ja) | 2000-03-03 | 2001-09-11 | Oakland Uniservices Ltd | 癌の組み合わせ療法 |
| CA2408622A1 (en) * | 2000-05-09 | 2001-11-15 | Creighton University | Methods for inhibiting proliferation and inducing apoptosis in cancer cells |
| JP2004505047A (ja) | 2000-07-28 | 2004-02-19 | キャンサー・リサーチ・テクノロジー・リミテッド | 複合治療による癌治療 |
| GB0121285D0 (en) | 2001-09-03 | 2001-10-24 | Cancer Res Ventures Ltd | Anti-cancer combinations |
| GB2386836B (en) | 2002-03-22 | 2006-07-26 | Cancer Res Ventures Ltd | Anti-cancer combinations |
| GB2394658A (en) | 2002-11-01 | 2004-05-05 | Cancer Rec Tech Ltd | Oral anti-cancer composition |
| WO2005105736A1 (en) | 2004-05-05 | 2005-11-10 | Novo Nordisk A/S | Novel compounds, their preparation and use |
| ES2352085T3 (es) | 2004-05-05 | 2011-02-15 | High Point Pharmaceuticals, Llc | Nuevos compuestos, su preparación y uso. |
| CN1302782C (zh) * | 2005-01-17 | 2007-03-07 | 北京京卫燕康药物研究所有限公司 | 盐酸吉西他滨溶液型注射剂 |
| ATE529404T1 (de) | 2005-06-30 | 2011-11-15 | High Point Pharmaceuticals Llc | Phenoxyessigsäuren als ppar-delta-aktivatoren |
| EP1979311B1 (en) | 2005-12-22 | 2012-06-13 | High Point Pharmaceuticals, LLC | Phenoxy acetic acids as ppar delta activators |
| CA2645719A1 (en) | 2006-03-09 | 2007-09-13 | High Point Pharmaceuticals, Llc | Compounds that modulate ppar activity, their preparation and use |
| AU2007307597A1 (en) | 2006-10-12 | 2008-04-17 | Institute Of Medicinal Molecular Design. Inc. | Carboxylic acid derivatives |
| US8633245B2 (en) | 2008-04-11 | 2014-01-21 | Institute Of Medicinal Molecular Design, Inc. | PAI-1 inhibitor |
| WO2014060381A1 (de) | 2012-10-18 | 2014-04-24 | Bayer Cropscience Ag | Heterocyclische verbindungen als schädlingsbekämpfungsmittel |
| EP2914587A1 (de) | 2012-10-31 | 2015-09-09 | Bayer CropScience AG | Neue heterocylische verbindungen als schädlingsbekämpfungsmittel |
| CN103319466B (zh) * | 2013-07-04 | 2016-03-16 | 郑州大学 | 含香豆素母核的1,2,3-三唑-氨基二硫代甲酸酯化合物、制备方法及其应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6034256A (en) * | 1997-04-21 | 2000-03-07 | G.D. Searle & Co. | Substituted benzopyran derivatives for the treatment of inflammation |
-
2000
- 2000-11-09 CZ CZ20021551A patent/CZ20021551A3/cs unknown
- 2000-11-09 CA CA002391416A patent/CA2391416A1/en not_active Abandoned
- 2000-11-09 NZ NZ517667A patent/NZ517667A/en unknown
- 2000-11-09 HU HU0204449A patent/HUP0204449A3/hu unknown
- 2000-11-09 EP EP00978535A patent/EP1231938A2/en not_active Withdrawn
- 2000-11-09 MX MXPA02004733A patent/MXPA02004733A/es not_active Application Discontinuation
- 2000-11-09 WO PCT/US2000/031039 patent/WO2001034137A2/en active IP Right Grant
- 2000-11-09 PL PL00355172A patent/PL355172A1/xx not_active Application Discontinuation
- 2000-11-09 IL IL14857900A patent/IL148579A0/xx unknown
- 2000-11-09 CN CN00815579A patent/CN1390139A/zh active Pending
- 2000-11-09 SK SK649-2002A patent/SK6492002A3/sk unknown
- 2000-11-09 TR TR2002/01245T patent/TR200201245T2/xx unknown
- 2000-11-09 EA EA200200545A patent/EA200200545A1/ru unknown
- 2000-11-09 KR KR1020027006027A patent/KR20020069512A/ko not_active Application Discontinuation
- 2000-11-09 JP JP2001536137A patent/JP2003513916A/ja not_active Withdrawn
- 2000-11-09 AU AU15990/01A patent/AU778829B2/en not_active Ceased
- 2000-11-09 BR BR0015490-3A patent/BR0015490A/pt not_active IP Right Cessation
- 2000-11-10 PE PE2000001206A patent/PE20010701A1/es not_active Application Discontinuation
- 2000-11-10 AR ARP000105955A patent/AR032432A1/es unknown
-
2002
- 2002-04-10 ZA ZA200202822A patent/ZA200202822B/xx unknown
- 2002-05-10 NO NO20022245A patent/NO20022245L/no not_active Application Discontinuation
-
2003
- 2003-01-29 HK HK03100750.7A patent/HK1050132A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1390139A (zh) | 2003-01-08 |
| PL355172A1 (en) | 2004-04-05 |
| BR0015490A (pt) | 2002-07-09 |
| NO20022245L (no) | 2002-07-09 |
| NO20022245D0 (no) | 2002-05-10 |
| SK6492002A3 (en) | 2003-09-11 |
| ZA200202822B (en) | 2003-09-23 |
| HUP0204449A2 (hu) | 2003-04-28 |
| PE20010701A1 (es) | 2001-07-07 |
| TR200201245T2 (tr) | 2004-08-23 |
| AU1599001A (en) | 2001-06-06 |
| KR20020069512A (ko) | 2002-09-04 |
| AR032432A1 (es) | 2003-11-12 |
| WO2001034137A2 (en) | 2001-05-17 |
| EP1231938A2 (en) | 2002-08-21 |
| WO2001034137A3 (en) | 2002-02-14 |
| HUP0204449A3 (en) | 2006-02-28 |
| IL148579A0 (en) | 2002-09-12 |
| CA2391416A1 (en) | 2001-05-17 |
| MXPA02004733A (es) | 2002-08-30 |
| JP2003513916A (ja) | 2003-04-15 |
| AU778829B2 (en) | 2004-12-23 |
| HK1050132A1 (zh) | 2003-06-13 |
| NZ517667A (en) | 2004-05-28 |
| EA200200545A1 (ru) | 2002-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CZ20021551A3 (cs) | Onkolytické kombinace pro léčení rakoviny | |
| CN102333779B (zh) | 苯并吡喃和苯并氧杂*pi3k抑制剂化合物和使用方法 | |
| TWI612040B (zh) | 作爲選擇性雌激素受體降解子（ｓｅｒｄ）之化合物及組合物 | |
| TWI331034B (en) | Inhibitors of cyclin-dependent kinases and their use | |
| ES2397664T3 (es) | Derivados de glucopiranósilo que contienen tienilo como antidiabéticos | |
| TW446704B (en) | Naphtho[2,3-B]heteroar-4-yl derivatives for treating metabolic disorders related to insulin resistance or hyperglycemia | |
| Haider et al. | Synthetic strategy and SAR studies of C-glucoside heteroaryls as SGLT2 inhibitor: A review | |
| JP2003531194A (ja) | プロスタグランジンｅ阻害薬としてフェニルおよびビアリール誘導体を用いる治療方法および該方法に有用な化合物 | |
| HU230727B1 (hu) | C-aril glükozid SGLT2 inhibitorok szintézis-intermedierei | |
| US4551282A (en) | Triphenylene derivatives | |
| US20150011618A1 (en) | Synthesis of polyhydroxy chromenone compounds and their anti-tumor effects | |
| EP2530079A1 (en) | Phenyl c-glucoside derivatives, preparation methods and uses thereof | |
| JP6461080B2 (ja) | 二重ｓｇｌｔ１／ｓｇｌｔ２阻害剤 | |
| TW200845961A (en) | Tricyclic compounds useful in treating iron disorders | |
| CN117597341A (zh) | 磺酰胺衍生物、其制备方法及其在医药上的应用 | |
| JP2003509419A (ja) | カルボン酸類およびアシルスルホンアミド類、そのような化合物を含む組成物、ならびに治療方法 | |
| WO2005079803A1 (en) | Compounds for treatment of cardiovascular diseases | |
| AU2041801A (en) | Oncolytic combinations for the treatment of cancer | |
| CN114149423A (zh) | 四氢吡啶并嘧啶二酮类衍生物、其制备方法及其在医药上的应用 | |
| KR20240089594A (ko) | 질소 함유 테트라시클릭 화합물, 이의 제조 방법 및 이의 의학적 응용 | |
| JP6223336B2 (ja) | 新規なエストロゲン受容体リガンド | |
| WO2001034198A2 (en) | Oncolytic combinations for the treatment of cancer | |
| WO2001034197A2 (en) | Oncolytic combinations for the treatment of cancer | |
| KR20160142887A (ko) | 폴리시클릭 hERG 활성화제 | |
| CN101146804B (zh) | 用作抗癌剂的5-（1，3-二芳基-1h-吡唑-4-基亚甲基）-噻唑烷-2，4-二酮衍生物 |